Intra Aortic Balloon Pumps Market to reach USD 528.25 Million by 2030, emerging at a CAGR of 3.2% and forecast 2023-2030
Intra-Aortic Balloon Pumps Market Overview
The global
Intra-Aortic Balloon Pumps Market
was USD 412.44 Million in 2022. It is projected to reach USD 528.25 Million by
2030, indicating a CAGR of 3.2% during the forecast period.
The Intra-Aortic Balloon Pumps Market
is a dynamic and rapidly evolving sector within the medical devices industry. These
pumps play a crucial role in cardiac care, offering temporary circulatory
support for patients experiencing heart failure or undergoing cardiac
procedures. The market has witnessed substantial growth in recent years, driven
by the rising incidence of cardiovascular diseases globally.
Technological advancements in IABP
design and functionality, coupled with an aging population and increasing
awareness about cardiovascular health, contribute to the market's expansion. As
healthcare systems strive to enhance patient outcomes and reduce recovery
times, the demand for innovative intra-aortic balloon pump solutions is
expected to remain robust.
Market key drivers
Intra-Aortic Balloon
Pumps market. Firstly, the escalating prevalence of cardiovascular diseases,
including coronary artery disease and heart failure, is a primary factor
propelling the demand for IABPs. Secondly, advancements in technology, such as
the development of more efficient and user-friendly balloon pump systems,
contribute to increased adoption rates.
Additionally, a growing
aging population and the consequent rise in the number of cardiovascular
procedures further stimulate Intra-Aortic
Balloon Pumps Market Growth. The emphasis on minimally
invasive cardiac interventions and the continuous efforts of healthcare
providers to improve patient outcomes also drive innovation in this market.
Market Key Players
Teleflex Incorporated, Zeon
Corporation, Tokai Medical Products, Inc., InterValve Medical Inc., Insightra
Medical, Inc., Getinge AB, Terumo Medical Corporation, Avante Medical Solutions
Ltd., Abiomed, and MERA
Market Segmentation
By Indication
Coronary Artery Diseases
Unstable Angina and Myocardial
Infarction
Chronic Heart Failure
By End User
Hospitals
Ambulatory Surgical Centers
Independent Catheterization Labs
Regional Analysis
North America has emerged as a key
contributor to the growth of the Intra-Aortic Balloon Pumps market, primarily
driven by the region's substantial providers of heart-related diseases
treatment and the well-established presence of intra-aortic balloon pump
companies. The market in this region has experienced significant expansion,
with the increasing prevalence of heart attacks in the United States playing a
pivotal role in driving market growth.
Notably, the Centers for Disease Control and
Prevention reports that around 805,000 individuals in the United States suffer
from heart attacks annually. Consequently, the surge in the incidence of
heart-related diseases in North America is expected to have a positive impact
on the demand for intra-aortic balloon pumps. These pumps are instrumental in
ensuring efficient blood flow, thus becoming a critical element in addressing
the healthcare needs of the region and contributing to the sustained growth of
the market in the long term.
Contact us:
Consegic
Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com
Comments
Post a Comment